Inflammatory Diseases and Vitamin E – What Do We Know and Where Do We Go?

Inflammatory Diseases and Vitamin E – What Do We Know and Where Do We Go?

inflammation-driven diseases and associated comorbidities, such as metabolic syndrome, obesity, fatty liver disease and cardiovascular disease cause significant global burden. There is increasing evidence that nutrients alter the inflammatory response and therefore can make a decisive contribution to the treatment of this disease.

Recently inflammasome, a multiprotein complex cytosol, was identified as a key player in inflammation and the development of a variety of inflammatory disorders mediated, with the nucleotide-binding domain and leucine-rich repeat domain pyrin (NLRP) 3 being the inflammasome flowers. Here we provide an overview of the pathway of cellular signals that underlie nuclear factor ‘kappa-light-chain-enhancer’ of activated B cells (NF-kB) – and the inflammatory process NLRP3-mediated, the pathogenesis of inflammatory diseases of atherosclerosis and non-disease alcoholic fatty liver (NAFLD);

Furthermore, we discussed the current state of knowledge for diet based intervention based medicine and to treat heart disease and NAFLD. Until now one of the most important antioxidants in the human diet is vitamin E. A variety of in vitro and in vivo studies suggest that various forms of vitamin E and its derivatives have anti-inflammatory activity. recent publications have shown that vitamin E – and perhaps metabolite of vitamin E – is a promising therapeutic approach for treating inflammatory diseases such as NAFLD. This article is protected by copyright. All rights reserved.

Inflammatory Diseases and Vitamin E - What Do We Know and Where Do We Go?
Inflammatory Diseases and Vitamin E – What Do We Know and Where Do We Go?

The effect of acetyl L-carnitine on zebrafish embryos: Phenotypic and gene expression studies

Acetyl L-carnitine (ALCAR), dietary supplements and antioxidants play an important role in the process that produces ATP bioenergy. Although there are reports of toxicity antioxidants, there is no information on the potential toxicity of ALCAR. Here, using zebrafish embryos, we investigated whether ALCAR modulated ATP synthesis, the generation of reactive oxygen species (ROS) and the expression of certain genes associated with major signaling pathways that control metabolism, growth, differentiation, apoptosis and oxidative stress. First, we show that ALCAR raises physiological responses, such as ATP levels increased after treatment ALCAR.

Simultaneously, increased expression of ROS, by-products from the synthesis of ATP, was observed in embryos ALCAR-treated. ROS expression consistent with a higher level of cysteine, a precursor of glutathione, reduced significantly. ALCAR not have a drastic effect on the overall development and heartbeat. analysis of polymerase chain by reaction of gene expression arrays that do not show significant changes in the expression of 83 genes related to 10-lane main signal including: a growth factor transformation β (TGFβ), winged and Int-1 (Wnt), nuclear factor κ-light – chain-enhancer activated B cells (NF-kB), Janus kinase / signal transducer and activator of transcription (JAK / STAT), p53, receptor Notch, Hedgehog,

Peroxisome proliferator-activated (PPAR), oxidative stress, and hypoxia pathways. Our results suggest that the expression of 83 genes related to these main signal path has not changed significantly. A subset of the etiology of oral carcinoma is associated with a high risk human papillomavirus (HR-HPV), with HPV16 being the most frequent HR-HPV types found in these carcinomas.

Donkey anti-Mouse IgG (H&L), F(ab)'2 Fragment

AS16-3437 1,0 mg
EUR 224

Donkey anti-Rabbit IgG (H&L), F(ab)'2 Fragment

AS16-3521 1,0 mg
EUR 206

Goat anti-Human IgG F(ab')2 Affinity purified, Unconjugated

AS21-4573 2 mg
EUR 206

Goat anti-Human IgG F(ab')2 Affinity purified, Unconjugated

AS21-4574 2 mg
EUR 206

Goat anti-Human IgG Fc, F(ab)'2 fragment, FITC conjugated

AS10-1236 0,5 mg
EUR 233

Goat anti-Human IgG Fc, Biotin conjugated, F(ab)'2 fragment

AS10-806 0,5 mg
EUR 206

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, Unconjugated

AS10-846 1 mg
EUR 206

Goat anti-Human IgG Fc, F(ab)'2 Fragment, DyLight® 488 conjugated, min, cross-reactivity to human IgA, IgM or IgG F(ab)'2 fragment

AS16-3353 0,5 mg
EUR 196

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, HRP conjugated

AS10-1009 0,5 mg
EUR 246

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, FITC conjugated

AS10-1011 0,5 mg
EUR 185

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, TRITC conjugated

AS10-1018 0,5 mg
EUR 185

Goat anti-Human IgG + IgA + IgM, F(ab)'2 fragment, HRP conjugated

AS10-1039 0,5 mg
EUR 246

Rabbit anti-Goat IgG (H&L), F(ab)'2 fragment, HRP conjugated

AS10-1045 0,5 mg
EUR 246

Goat anti-Human IgA (alpha chain), F(ab)'2 fragment, FITC conjugated

AS10-1076 0,5 mg
EUR 239

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Biotin conjugated

AS10-1081 0,5 mg
EUR 233

Goat anti-Human IgA (alpha chain), F(ab)'2 fragment, TRITC conjugated

AS10-1097 0,5 mg
EUR 233

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, ALP conjugated

AS10-1139 0,5 mg
EUR 233

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, Biotin conjugated

AS10-1200 0,5 mg
EUR 246

Goat anti-Human IgA + IgG + IgM, F(ab)'2 fragment, ALP conjugated

AS10-1222 0,5 mg
EUR 233

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, ALP conjugated

AS10-1237 0,5 mg
EUR 246

Goat anti-Human IgA + IgG + IgM, F(ab)'2 fragment, Biotin conjugated

AS10-1253 0,5 mg
EUR 233

Goat anti-Human IgA + IgG + IgM, F(ab)'2 fragment, FITC conjugated

AS10-1275 0,5 mg
EUR 233

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, TRITC conjugated

AS10-1289 0,5 mg
EUR 175

Goat anti-Human IgG (H&L), F(ab)'2 fragment, FITC conjugated

AS10-1295 0,5 mg
EUR 185

Goat anti-Human IgA + IgG + IgM, F(ab)'2 fragment, TRITC conjugated

AS10-1306 0,5 mg
EUR 233

Goat anti-Human IgA heavy (alpha chain), F(ab)'2 fragment, Unconjugated

AS10-743 1 mg
EUR 206

Goat anti-Human IgG (H&L), F(ab)'2 fragment, ALP conjugated

AS10-774 0,5 mg
EUR 206

Goat anti-Human IgG (H&L), F(ab)'2 fragment, Biotin conjugated

AS10-775 0,5 mg
EUR 206

Goat anti-Human IgG (H&L), F(ab)'2 fragment, HRP conjugated

AS10-779 0,5 mg
EUR 206

Goat anti-Human IgG Fc, F(ab)'2 fragment, Affinity purified, Unconjugated

AS10-805 1 mg
EUR 233

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, ALP conjugated

AS10-848 0,5 mg
EUR 233

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, Biotin conjugated

AS10-849 0,5 mg
EUR 206

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, HRP conjugated

AS10-852 0,5 mg
EUR 206

Goat anti-Human IgG (H&L), F(ab)'2 fragment, TRITC conjugated

AS10-946 0,5 mg
EUR 185

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, FITC conjugated

AS10-967 0,5 mg
EUR 175

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, FITC conjugated

AS10-991 0,5 mg
EUR 246

Rabbit anti-Goat IgG (H&L), F(ab)'2 fragment, Biotin conjugated

AS10-997 0,5 mg
EUR 246

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, HRP conjugated

AS10-998 0,5 mg
EUR 185

Donkey anti-Mouse IgG (H&L), F(ab)'2 Fragment, FITC conjugated

AS16-3450 0,5 mg
EUR 206

Donkey anti-Mouse IgG (H&L), F(ab)'2 Fragment, HRP conjugated

AS16-3454 0,5 mg
EUR 233

Donkey anti-Mouse IgG (H&L), F(ab)'2 Fragment, TRITC conjugated

AS16-3467 0,5 mg
EUR 206

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, Affinity purified, Unconjugated

AS10-1029 1 mg
EUR 246

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated

AS10-1163 1 mg
EUR 175

Goat anti-Human IgA + IgG + IgM, F(ab)'2 fragment, Affinity purified, Unconjugated

AS10-1184 1 mg
EUR 175

TSH (beta) | thyroid stimulating hormone (Affinity purified, F(ab)2' fragment, goat antibody)

AS10-1325 0,5 mg
EUR 532

Goat anti-Human IgA heavy (alpha chain), F(ab)'2 fragment, Biotin conjugated

AS10-745 0,5 mg
EUR 233

Goat anti-Human IgA heavy (alpha chain), F(ab)'2 fragment, HRP conjugated

AS10-746 0,5 mg
EUR 206

Goat anti-Human IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated

AS10-773 1 mg
EUR 206

Rabbit anti-Goat IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated

AS10-960 1 mg
EUR 233

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, DyLight® 488 conjugated

AS10-1220 0,5 mg
EUR 206

Donkey anti-Mouse IgG (H&L), F(ab)'2 fragment, DyLight® 633 conjugated

AS12-2182 0,5 mg
EUR 206

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, DyLight® 633 conjugated

AS12-2189 0,5 mg
EUR 206

Rabbit anti-Goat IgG (H&L), F(ab)'2 fragment, DyLight® 800 conjugated

AS12-2381 0,5 mg
EUR 233

Donkey anti-Mouse IgG (H&L), F(ab)'2 fragment, DyLight® 800 conjugated

AS12-2428 0,5 mg
EUR 246

Donkey anti-Rabbit IgG (H&L), F(ab)'2 Fragment, DyLight® 488 conjugated

AS16-3526 0,5 mg
EUR 233

Goat anti-Rabbit IgG (H&L), F(ab)'2 Fragment, DyLight® 488 conjugated

AS16-3527 0,5 mg
EUR 202

Goat anti-Rat IgG (H&L), F(ab)'2 fragment, HRP conjugated, min,reactivity to human, mouse IgG

AS10-1145 0,5 mg
EUR 246

Goat anti-Human IgG Fc, F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity bovine/mouse/rabbit serum

AS10-814 0,5 mg
EUR 246

Goat anti-Human IgG Fc, F(ab)'2 fragment, HRP conjugated, min, cross-reactivity bovine/mouse/rabbit serum

AS10-817 0,5 mg
EUR 233

Goat anti-Human IgG Fc, F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to bovine,mouse,rabbit serum

AS10-1001 0,5 mg
EUR 246

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to human IgG/serum

AS10-1002 0,5 mg
EUR 233

Goat anti-Rat IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to human, mouse IgG

AS10-1023 0,5 mg
EUR 246

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to human IgG/serum

As10-1071 0,5 mg
EUR 233

Goat anti-Rat IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to human, mouse IgG

AS10-1088 0,5 mg
EUR 246

Goat anti-Human IgG Fc, F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to bovine,mouse,rabbit serum

AS10-1099 0,5 mg
EUR 246

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to human IgG/serum

AS10-1189 0,5 mg
EUR 233

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, ALP conjugated, min, cross-reactivity to human IgG/serum

AS10-1193 0,5 mg
EUR 246

Goat anti-Rat IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to human, mouse IgG

AS10-1234 0,5 mg
EUR 246

Goat anti-Human IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity bovine/mouse/rabbit serum

AS10-782 0,5 mg
EUR 233

Goat anti-Human IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity bovine/mouse/rabbit serum

AS10-785 0,5 mg
EUR 233

Goat anti-Human IgG Fc, F(ab)'2 fragment, ALP conjugated, min, cross-reactivity to bovine/mouse/rabbit serum

AS10-813 0,5 mg
EUR 246

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to human IgG/serum

AS10-981 0,5 mg
EUR 233

Goat anti-Human IgM (µ chain), F(ab)'2 Fragment, min, cross-reactivity to IgG from human or mouse

AS16-3371 1,0 mg
EUR 238

Goat anti-Human IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to bovine,mouse,rabbit serum

AS10-1015 0,5 mg
EUR 233

Rabbit anti-Goat IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to human, mouse,Rat IgG

AS10-1058 0,5 mg
EUR 246

Rabbit anti-Goat IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to human, mouse,Rat IgG

AS10-1065 0,5 mg
EUR 246

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to human IgG or IgA

AS10-1090 0,5 mg
EUR 233

Goat anti-Human IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to bovine,mouse,rabbit serum

AS10-1157 0,5 mg
EUR 233

Goat anti-Rat IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to human, mouse IgG

AS10-1215 1 mg
EUR 233

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to human IgG or IgA

AS10-1287 0,5 mg
EUR 259

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to human IgA+IgG

AS10-1296 1 mg
EUR 233

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, ALP conjugated, min, cross-reactivity to human IgG or IgA

AS10-1298 0,5 mg
EUR 273

Goat anti-Human IgG (H&L), F(ab)'2 fragment, ALP conjugated, min, cross-reactivity to bovine/mouse/rabbit serum

AS10-781 0,5 mg
EUR 206

Goat anti-Human IgG Fc, F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to bovine/mouse/rabbit serum

AS10-812 1 mg
EUR 233

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to human IgG or IgA

AS10-959 0,5 mg
EUR 246

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to human IgG/serum

AS10-961 1 mg
EUR 233

Goat anti-Human IgM (µ chain), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to human IgG or IgA

AS10-979 0,5 mg
EUR 273

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to bovin, human, mouse IgG/serum

AS10-1042 0,5 mg
EUR 233

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to bovine,human, mouse IgG/serum

AS10-1059 0,5 mg
EUR 233

Rabbit anti-Goat IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to human, mouse,Rat IgG

AS10-1077 1 mg
EUR 246

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to bovine,human, mouse IgG/serum

AS10-1146 0,5 mg
EUR 233

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to bovine,human, mouse IgG/serum

AS10-1153 0,5 mg
EUR 233

Goat anti-Rat IgG (H&L), F(ab)'2 fragment, DyLight® 488 conjugated, min, cross-reactivity to human, mouse lgG

AS10-1217 0,5 mg
EUR 259

Goat anti-Human IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to bovine/mouse/rabbit serum

AS10-780 1 mg
EUR 233

Goat anti-Rat IgG (H&L), F(ab)'2 fragment, DyLight® 550 conjugated, min, cross-reactivity to human, mouse lgG

AS12-1980 0,5 mg
EUR 246

Goat anti-Human IgG Fc, F(ab)'2 Fragment, min, cross-reactivity to Human IgA/IgM, Bovine, Horse, Mouse, Rabbit Serum

AS16-3350 0,5 mg
EUR 216

Goat anti-Mouse IgG (H&L), F(ab)'2 Fragment, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG

AS16-3459 1,0 mg
EUR 284

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to bovine, human, mouse IgG/serum

AS10-982 1 mg
EUR 190

Goat anti-Human IgG Fc, F(ab)'2 Fragment, min, cross-reactivity to bovine, horse, mouse or rabbit serum proteins, mouse IgG1

AS16-3356 1,0 mg
EUR 238

Goat anti-Mouse IgG (H&L), F(ab)'2 Fragment, min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein

AS16-3461 1,0 mg
EUR 252

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, ALP (alkaline phosphatase) conjugated, min, cross-reactivity to bovine,human, mouse IgG/serum

AS10-1017 0,5 mg
EUR 233

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, DyLight® 800 conjugated, min, cross-reactivity to human IgG or serum proteins

AS12-2436 0,5 mg
EUR 220

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, ALP conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG

AS16-3441 0,5 mg
EUR 264

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG

AS16-3445 0,5 mg
EUR 300

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG

AS16-3452 0,5 mg
EUR 284

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG

AS16-3456 0,5 mg
EUR 300

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG

AS16-3468 0,5 mg
EUR 284

Goat anti-Rabbit IgG (H&L), F(ab)'2 Fragment, min, cross-reactivity to non-immunoglobulin rabbit serum proteins and human serum proteins

AS16-3530 1,0 mg
EUR 203

Goat anti-Human IgG Fc, F(ab)'2 Fragment, FITC conjugated, min, cross-reactivity to bovine, horse, mouse or rabbit serum proteins, mouse IgG1

AS16-3354 0,5 mg
EUR 238

Goat anti-Human IgG Fc, F(ab)'2 Fragment, HRP conjugated, min, cross-reactivity to bovine, horse, mouse or rabbit serum proteins, mouse IgG1

AS16-3355 0,5 mg
EUR 245

Goat anti-Human IgG Fc, F(ab)'2 Fragment, TRITC conjugated, min, cross-reactivity to bovine, horse, mouse or rabbit serum proteins, mouse IgG1

AS16-3358 0,5 mg
EUR 275

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, ALP conjugated min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein

AS16-3440 0,5 mg
EUR 257

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Biotin-conjugated, min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein

AS16-3462 0,5 mg
EUR 238

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein

AS16-3463 0,5 mg
EUR 214

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein

AS16-3464 0,5 mg
EUR 183

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein

AS16-3465 0,5 mg
EUR 214

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, DyLight® 550 conjugated,min, cross-reactivity to bovine, horse, human, pig or rabbit serum proteins

AS12-1945 0,5 mg
EUR 206

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, DyLight® 550 conjugated,min, cross-reactivity to bovine, human, or Mouse lgG or serum proteins

AS12-1968 0,5 mg
EUR 206

Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, DyLight® 594 conjugated, min, cross-reactivity to bovine, human, or Mouse lgG or serum proteins

AS12-2083 0,5 mg
EUR 206

Goat anti-Rabbit IgG (H&L) -F(ab)'2 fragment, DyLight® 650 conjugated, min, cross-reactivity to bovine, human, or Mouse lgG or serum proteins

AS12-2337 0,5 mg
EUR 220

Goat anti-Mouse IgG (H&L), F(ab)'2 Fragment, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG (highly absorbed against rat IgG)

AS16-3460 1,0 mg
EUR 406

Donkey anti-Rabbit IgG (H&L), F(ab)'2 Fragment, min, cross-reactivity to Bovine, Chicken, Goat, Guinea Pig, Hamster, Horse, Human, Mouse, Rat or Sheep

AS16-3522 0,5 mg
EUR 213

Donkey anti-Mouse IgG (H&L), F(ab)'2 Fragment, min, cross-reactivity to bovine, chicken, goat, guinea pig, hamster, horse, human, rabbit, rat or sheep IgG

AS16-3458 0,5 mg
EUR 213

Goat anti-Mouse IgG (H&L), F(ab)'2 Fragment, ALP conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG (highly absorbed against rat IgG)

AS16-3442 0,5 mg
EUR 381

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG (highly absorbed against rat IgG)

AS16-3446 0,5 mg
EUR 442

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG (highly absorbed against rat IgG)

AS16-3457 0,5 mg
EUR 442

Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG (highly absorbed against rat IgG)

AS16-3469 0,5 mg
EUR 406

Donkey anti-Mouse IgG (H&L), F(ab)'2 fragment, ALP conjugate, min, cross-reactivity to bovine, chicken, goat, guinea pig, hamster, horse, human, rabbit, rat or sheep IgG

AS16-3439 0,5 mg
EUR 360

Donkey anti-Mouse IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to bovine, chicken, goat, guinea pig, hamster, horse, human, rabbit, rat or sheep IgG

AS16-3444 0,5 mg
EUR 300

Donkey anti-Mouse IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to bovine, chicken, goat, guinea pig, hamster, horse, human, rabbit, rat or sheep IgG

AS16-3451 0,5 mg
EUR 287

Donkey anti-Mouse IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to bovine, chicken, goat, guinea pig, hamster, horse, human, rabbit, rat or sheep IgG

AS16-3455 0,5 mg
EUR 300

Donkey anti-Mouse IgG (H&L), F(ab)'2 fragment, TRITC conjugate, min, cross-reactivity to bovine, chicken, goat, guinea pig, hamster, horse, human, rabbit, rat or sheep IgG

AS16-3466 0,5 mg
EUR 287

Donkey anti-Mouse IgG (H&L), F(ab)'2 fragment, DyLight® 633 conjugated, min, cross-reactivity to bovine, chicken, goat, guinea pig, hamster, horse, human, rabbit, rat or sheep IgG

AS12-2183 0,5 mg
EUR 334

RELA (Ab-276) Antibody

MBS7132551-01mL 0.1mL
EUR 270

Oncogenic role of HR-HPV is highly dependent on the overexpression of E6 and E7 Oncoproteins, which, in turn, causes the degradation of p53 and PRB, respectively. In addition, it has been suggested that HR-HPV Oncoproteins involved in the regulation of nuclear factor kappa-light-chain-enhancer activated B cells (NF-kB), stimulating cancer development and metastasis. Previously, we reported that the HPV16 E7 oncoprotein to promote Pirin upregulation resulted in increased epithelial-mesenchymal transition (EMT) and cell migration, with Pirin become oxidative stress sensor and activator of NF-kB.

Tony

Related Posts

Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?

Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?

Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility

Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility

Glyoxal and Methylglyoxal as E-cigarette Vapor Ingredients-Induced Pro-Inflammatory Cytokine and Mucins Expression in Human Nasal Epithelial Cells

Glyoxal and Methylglyoxal as E-cigarette Vapor Ingredients-Induced Pro-Inflammatory Cytokine and Mucins Expression in Human Nasal Epithelial Cells

MIP-1α Expression Induced by Co-Stimulation of Human Monocytic Cells with Palmitate and TNF-α Involves the TLR4-IRF3 Pathway and Is Amplified by Oxidative Stress

MIP-1α Expression Induced by Co-Stimulation of Human Monocytic Cells with Palmitate and TNF-α Involves the TLR4-IRF3 Pathway and Is Amplified by Oxidative Stress

No Comment

Leave a Reply

Your email address will not be published.

December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Recent Posts

Categories

Tags

Pages